COMBAT CANCER
Fundraising activities to support the leading UK cancer research organisations
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit of £4,734.33 for the year ended 31 March 2025, with total incoming resources of £50,009.00 against charitable expenditure of £54,743.33. Despite the deficit, unrestricted funds carried forward remain at £50,631.44, and the trustees confirm that the reserves policy target of six months' operating costs has been achieved. The financial statements were prepared on a going concern basis with no material uncertainties identified.
What the accounts disclose
“These relate mainly to online donations received in support of the stated objectives” — page 10
“It is the Charity’s aim to ensure that unrestricted funds not presently committed to future projects be maintained in accordance with the Charity’s Commission guidelines of 6 months operating costs. This has now been achieved” — page 5
Trustees
- Elizabeth McDonald
- Justin Grosvenor
- Sharon Stanley
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £50k | £55k |
| 31/03/2024 | £55k | £58k |
| 31/03/2023 | £48k | £33k |
| 31/03/2022 | £33k | £14k |
| 31/03/2021 | £27k | £22k |
Common questions
Is COMBAT CANCER financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit of £4,734.33 for the year ended 31 March 2025, with total incoming resources of £50,009.00 against charitable expenditure of £54,743.33. Despite the deficit, unrestricted funds carried forward remain at £50,631.44, and the trustees confirm that the reserves policy target of six months' operating costs has been achieved. The financial statements were prepared on a going concern basis with no material uncertainties identified. Its FY2025 accounts were independently examined.